David Weinstein

Author:

David A. Weinstein

ISBN #:

0471515574

Author:

David A. Weinstein

ISBN #:

0471515582

Author:

David A. Weinstein

ISBN #:

0471852694

Author:

David A. Weinstein

ISBN #:

0471852708

Author:

David E. Weinstein

ISBN #:

0262090406

Author:

David Weinstein

ISBN #:

0134591577

Author:

David Weinstein

ISBN #:

0324017944

Author:

David Weinstein

ISBN #:

0521026865

US Patent:

7233668, Jun 19, 2007

Filed:

May 23, 2002

Appl. No.:

10/155582

Inventors:

David J. Weinstein - Potomac MD, US
Allan M. Weinstein - Potomac MD, US
Paul A Kline - Gaithersburg MD, US
Jon L. Roberts - Great Falls VA, US

Assignee:

Sharestream, LLC - Washington DC

International Classification:

H04N 7/167
H04L 9/32

US Classification:

380201, 713189, 713193, 726 2

Abstract:

A system and method for securing intellectual property rights in distributed intellectual property. The present invention grants and polices rights in electronically distributed intellectual property. Use limitations are established by agreement by the content provider and the client. The use limitations are reflected in time-based, usage-based and player based component codes that are used to determine if the client is entitled to use the intellectual property. The present invention further protects the intellectual property from unauthorized use by encrypting the intellectual property with a key created from some or all of the component codes. As the component codes are known to both the client and the content provider, no key exchange is required by the present invention.

US Patent:

7888381, Feb 15, 2011

Filed:

Jun 13, 2006

Appl. No.:

11/451660

Inventors:

Jingwu Duan - Yardley PA, US
Zhonghui Lu - King of Prussia PA, US
David S. Weinstein - East Windsor NJ, US
Bin Jiang - Norristown PA, US

Assignee:

Bristol-Myers Squibb Company - Princeton NJ

International Classification:

C07D 231/56
A01N 43/56

US Classification:

514406, 5483601

Abstract:

Non-steroidal compounds are provided which are useful in treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-κB activity including obesity, diabetes, inflammatory and immune diseases, and have the structure of formula (I).

US Patent:

8131993, Mar 6, 2012

Filed:

Jun 18, 2007

Appl. No.:

11/764438

Inventors:

Paul A. Kline - Gaithersburg MD, US
Allan M. Weinstein - Potomac MD, US
David J. Weinstein - Potomac MD, US
Jon L. Roberts - Great Falls VA, US
Sawant Nitin - Gaithersburg MD, US

Assignee:

Sharestream, LLC - Washington DC

International Classification:

H04L 9/00
G06F 21/00

US Classification:

713150, 713189, 713193, 726 2, 726 7, 726 27, 726 29, 705 71, 705310, 705901, 705907, 709203, 380277

Abstract:

A system and method for securing intellectual property rights in distributed intellectual property. Rights are granted and policed in electronically distributed intellectual property. Use limitations are established by agreement by the content provider and the client. The use limitations are reflected in time-based, usage-based and player based component codes that are used to determine if the client is entitled to use the intellectual property. Intellectual property is protected from unauthorized use by encrypting the intellectual property with a key created from some or all of the component codes. As the component codes are known to both the client and the content provider, no key exchange is required.

US Patent:

8304539, Nov 6, 2012

Filed:

Feb 5, 2009

Appl. No.:

12/866270

Inventors:

Jingwu Duan - Yardley PA, US
David S. Weinstein - East Windsor NJ, US
Bin Jiang - Norristown PA, US

Assignee:

Bristol-Myers Squibb Company - Princeton NJ

International Classification:

C07D 491/147
C07D 413/00

US Classification:

544126, 546 83

Abstract:

Novel non-steroidal compounds are provided which are useful in treating diseases or disorders associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-κB activity, including metabolic and inflammatory and immune diseases or disorders, having the structure of formula (I): an enantiomer, diastereomer, or taυtomer thereof, or a prodrug ester thereof, or a pharmaceutically-acceptable salt thereof, in which: Z is heterocyclo or heteroaryl; •A is a S- to 8-membered carbocyclic ring or a S- to 8-membered heterocyclic ring; Band Brings are pyridyl rings, wherein the Band Brings are each fused to the A ring and the Bring is optionally substituted by one to three groups which are the same or different and are independently selected from R, R, and R, and the Bring is optionally substituted by one to three groups which are the same or different and are independently selected from R, R, and RJ, J, and Jare at each occurrence the same or different and are independently -AQA-; Q is a bond, O, S, S(O), or S(O); Aand Aare the same or different and are at each occurrence independently selected from a bond, Calkylene, substituted Calkylene, Calkenylene, and substituted Calkenylene, provided that Aand Aare chosen so that ring A is a 5- to 8-membered carbocyclic or heterocyclic ring; Rto Rare as defined herein.

US Patent:

8615656, Dec 24, 2013

Filed:

Jan 9, 2012

Appl. No.:

13/346291

Inventors:

David Weinstein - Laurel MD, US
Scott Lewis Dyer - Bedford MA, US

Assignee:

The MITRE Corporation - McLean VA

International Classification:

H04L 9/32
G06F 3/00

US Classification:

713168

Abstract:

A Secure Remote Peripheral Encryption Tunnel (SeRPEnT) can be implemented in a portable embedded device for the Universal Serial Bus (USB) with a much more restricted attack surface than a general purpose client computer. The SeRPEnT device can comprise a small, low-power “cryptographic switchboard” that can operate in a trusted path mode and a pass-through mode. In the trusted path mode, the SeRPEnT device can tunnel connected peripherals through the client to a server with Virtual Machine (VM)-hosted applications. In the pass-through mode, the SeRPEnT device can pass-through the connected peripherals to the client system, allowing normal use of the local system by the user. SeRPEnT can also enable secure transactions between the user and server applications by only allowing input to the VMs to originate from the SeRPEnT device.

US Patent:

8627415, Jan 7, 2014

Filed:

Jan 31, 2012

Appl. No.:

13/362436

Inventors:

Paul A. Kline - Gaithersburg MD, US
Sawant Nitin - Gaithersburg MD, US
Allan M. Weinstein - Potomac MD, US
David J. Weinstein - Potomac MD, US
Jon L. Roberts - Great Falls VA, US

Assignee:

Sharestream, LLC - Washington DC

International Classification:

H04L 9/00
G06F 21/00
G06F 7/04

US Classification:

726 4, 726 6, 726 7, 713150, 713168, 380201, 380255, 705 50, 705 71, 705310, 705901

Abstract:

A method for securing intellectual property includes establishing contact between an IP server and a client. At least two component codes are shared and pre-stored in both the player and the server prior to ordering the intellectual property. The IP server accepts an order for an intellectual property product from the client. The IP server creates a shared private key based on the pre-stored shared component codes and an additional shared component code at the time the intellectual property product is ordered. The shared private key is not distributed to the player software. The IP server encrypts the intellectual property product with the created shared private key prior to distribution to the client. The intellectual property product further comprises content data and rights data in digital form. The IP server electronically distributes the intellectual property product to the client in encrypted form without the shared private key.

US Patent:

7361654, Apr 22, 2008

Filed:

Jan 12, 2006

Appl. No.:

11/330553

Inventors:

James Sheppeck - Newtown PA, US
T. G. Murali Dhar - Newtown PA, US
Lidia Doweyko - Long Valley NJ, US
John Gilmore - Yardley PA, US
David Weinstein - East Windsor NJ, US
Bingwei V. Yang - Belle Mead NJ, US
Arthur M. Doweyko - Long Valley NJ, US

Assignee:

Bristol-Myers Squibb Co. - Princeton NJ

International Classification:

A61K 31/5377
A61K 31/506
A61K 31/501
A61K 31/497
A61K 31/496
A61K 31/4439
A61K 31/427
A61K 31/426
A61K 31/4196
A61K 31/4168

US Classification:

5142355, 51425213, 51425205, 5142531, 51425402, 514256, 514274, 514340, 514342, 514371, 514383, 514398, 514392, 544111, 544238, 544298, 544359, 5462681, 5462684, 548190, 5483147, 5483325, 5482654, 548233, 5483044

Abstract:

The present invention relates to new class of non-steroidal compounds which are useful in treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-κB activity including obesity, diabetes, inflammatory- and immune-associated diseases, and have the structure.

US Patent:

20130227694, Aug 29, 2013

Filed:

Mar 29, 2012

Appl. No.:

13/434146

Inventors:

David Weinstein - Laurel MD, US
David Keppler - Herndon VA, US

Assignee:

The MITRE Corporation - McLean VA

International Classification:

G06F 21/00

US Classification:

726 25

Abstract:

A mobile device charging station configured to analyze, measure and respond to/correct the state of a mobile device. The charging station can employ an embedded cryptographic subsystem that can make use of anti-tamper/tamper evident techniques to protect stored firmware images/cryptographic material.